Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03227718 · ClinicalTrials.gov registry record
VOR Suppression in Non-Gymnast Adults
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 12
- Enrollment target
NCT03227718: Completed study, sponsored by Virginia Commonwealth University.
NCT03227718 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03227718 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The researchers hypothesize that there is a correlation between Vestibulo-ocular reflex (VOR) performance and innate athletic skill level. A similar study was conducted in female, young adult gymnasts where a correlation was shown between VOR performance and gymnastic skill level. However, the results from this study did not suggest that VOR differences develop as a result of practice; rather that the differences in VOR may simply allow some individuals to become better performers. In this study the researchers would like to extend the population to adults both with and without a background in gymnastics to determine the natural relationship between VOR and innate athletic potential.
Primary Outcome
amplitude of head v. eye velocities
Interventions
- BEHAVIORAL VOR and coordination measurements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2017-04-18 |
What the finished NCT03227718 record still lists
NCT03227718 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which VOR and coordination measurements is the first listed.
NCT03227718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03227718 about?
NCT03227718 is a clinical study titled "VOR Suppression in Non-Gymnast Adults". The researchers hypothesize that there is a correlation between Vestibulo-ocular reflex (VOR) performance and innate athletic skill level. A similar study was conducted in female, young adult gymnasts where a correlation was shown between VOR performance and gymnastic skill level. However, the resul...
What is the current status of trial NCT03227718?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2017-01-01. Estimated completion is 2017-04-18.
What interventions are being tested in trial NCT03227718?
The interventions under investigation include: VOR and coordination measurements (BEHAVIORAL).
Who is sponsoring clinical trial NCT03227718?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI